UK Earnings, Trading Statements Calendar | |
Thursday, October 22 | |
Inchcape | Q3 Interim Management Statement |
Ladbrokes | Q3 Interim Management Statement |
Lombard Risk Management | Half Year Results |
Stobart | Half Year Results |
Rathbone Brothers | Q3 Interim Management Statement |
Travis Perkins | Q3 Interim Management Statement |
GKN | Q3 Interim Management Statement |
Anglo American | Q3 Production Report |
Britvic | Trading Statement |
Debenhams | Full Year Results |
Foxtons | Trading Statement |
Phoenix Group | Q3 Interim Management Statement |
RELX | Trading Statement |
SEGRO | Trading Statement |
London Stock Exchange Group | Q3 Interim Management Statement |
Polyus Gold International | Trading Statement |
Mothercare | Trading Statement |
Friday, October 23 | |
William Hill | Q3 Interim Management Statement |
Shire | Q3 Results |
Dechra Pharmaceuticals | AGM Trading Statement |
Monday, October 26 | |
WPP | Q3 Trading Statement |
Avacta Group | Full Year Group |
Tuesday, October 27 | |
BP | Q3 Results |
Utilitywise | Full Year Results |
St James's Place | Q3 Interim Management Statement |
Carpetright | Trading Statement |
Shoe Zone | Trading Statement |
Bloomsbury Publishing | Half Year Results |
International Personal Finance | Q3 Interim Management Statement |
Wednesday, October 28 | |
British American Tobacco | Q3 Interim Management Statement |
Standard Life | Q3 Interim Management Statement |
Next | Q3 Trading Statement |
Antofagasta | Q3 Production Report |
GlaxoSmithKline | Q3 Results |
Lloyds Banking Group | Q3 Interim Management Statement |
Redefine International | Full Year Results |
Shanks Group | Trading Statement |
JZ Capital Partners | Half Year Results |
Braemar Shipping | Half Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. |
Moderna says it hit its 2023 COVID vaccine sales goal
Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.
Read more